Skip to main content
# العنوان المشارك في البحث سنة البحث
81 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom أ.د.أمانى محمد على أحمد 2018
82 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
أ.د.أمانى محمد على أحمد 2018
83 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom د. طارق محمد عبدالمنعم محمد السبع أحمد 2018
84 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
د. عزه شبل سيد محمود 2018
85 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources أ.د.هبة عبدالرازق سيد حسين 2018
86 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom د. سمر محمد منصور 2018
87 Bloodstream Infections in Febrile Neutropenic
Pediatric Cancer Patients: Microbiological and
Sepsis Biomarkers Insight
د. خالد فتحى رياض عثمان 2018
88 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute
أ.د.هبة عبدالرازق سيد حسين 2018
89 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines د. خالد فتحى رياض عثمان 2017
90 P-458 Pain Experience Profile in Children with Cancer: Prospective Analysis of 2216 Treatment Days in a Developing Country د. خالد فتحى رياض عثمان 2017